Jefferies & Co Upgrades Healthways (HWAY) to Buy
HWAY Hot Sheet
Rating Summary:3 Buy, 6 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 1
Jefferies & Co upgrades Healthways (Nasdaq: HWAY) from Hold to Buy. Price target increased from $15 to $20.
To see more analyst ratings on HWAY Click Here.
Healthways, Inc. provides specialized Health and Care Support solutions.
To see more analyst ratings on HWAY Click Here.
Healthways, Inc. provides specialized Health and Care Support solutions.
You May Also Be Interested In
- UPDATE: Nomura Securities Upgrades Central European Distribution (CEDC) to Neutral; Strategic Alliance with Russian Standard
- UPDATE: Auriga Upgrades Lifepoint Holdings (LPNT) to Buy; Use Recent Pullback As Opportunity
- UPDATE: UBS Upgrades Assured Guaranty (AGO) to Buy; Opportunity Opens After Recent Dip on Moody's Review
Create E-mail Alert Related Categories
UpgradesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
